Navigation Links
Moderate drinking can reduce risks of Alzheimer's dementia and cognitive decline
Date:12/29/2008

MAYWOOD, Ill. -- Moderate drinkers often have lower risks of Alzheimer's disease and other cognitive loss, according to researchers who reviewed 44 studies.

In more than half of the studies, published since the 1990s, moderate drinkers of wine, beer and liquor had lower dementia risks than nondrinkers. In only a few studies were there increased risks.

"Alcohol is a two-edged sword," said Michael Collins, Ph.D., a professor and neuroscientist at Loyola University Chicago Stritch School of Medicine and lead author of the refereed report in the journal Alcoholism: Clinical and Experimental Research. "Too much is bad. But a little might actually be helpful."

Moderate alcohol consumption generally is defined as 1 drink or less per day for women and 1-2 drinks or less per day for men.

The article will be published in the February 2009 issue of the journal, and is available on line now. The article summarizes a roundtable, organized by Collins, held at the Research Society on Alcoholism meetings in Chicago in 2007.

"The pathological damage and vast social havoc from addiction to and abuse of alcohol are well known, and of necessity should continue to receive primary attention by doctors, scientific researchers and health professionals," Collins and colleagues write. "However, light-to-moderate responsible alcohol consumption "appears to carry certain health benefits."

Long-term alcohol abuse can cause memory loss and impair cognitive function. It's unknown why moderate alcohol use appears to have the opposite effect. One theory is that the well-known cardiovascular benefits of moderate alcohol consumption also can reduce the risk of mini strokes that cause dementia.

Collins and another Loyola professor, neuroscientist Edward Neafsey, Ph.D., suggest a second possible explanation. Small amounts of alcohol might, in effect, make brain cells more fit. Alcohol in moderate levels stresses cells and thus t
'/>"/>

Contact: Jim Ritter
jritter@lumc.edu
708-216-2445
Loyola University Health System
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Medarex to Receive Milestone Payment for Approval of STELARA(TM) (Ustekinumab) for the Treatment of Moderate to Severe Plaque Psoriasis
2. FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia – Painful Sexual Intercourse : Agency Grants New Indication for Bothersome Vaginal Symptom Associated with Menopause
3. FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia - Painful Sexual Intercourse
4. Can rectal vitamin E induce remission in patients with mild to moderate ulcerative colitis?
5. Enbrel(R) (etanercept) Is the First Biologic With Published Efficacy and Safety Data for up to a Decade of Continuous Use for the Treatment of Moderate to Severe Rheumatoid Arthritis
6. SEAL Indiana Reports More Than Half of Indianapolis Area School Kids Treated by Program Have Moderate or Severe Dental Decay
7. Moderate Aerobics May Ease Insomnia Symptoms
8. Drug Works Well for Moderate-to-Severe Psoriasis
9. FDA Approves Taclonex Scalp(R) - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis
10. Ad in USA TODAY Touts Benefits of Moderate UV Exposure
11. Moderate alcohol consumption in middle age can lower cardiac risk

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...China, Nov. 9 /PRNewswire-FirstCall/ - Hard To Tre...nced today that Novartis, a US$41 billion internat...e in HTDS, H1N1 Vaccine partner, Zhejiang Tianyuan... Novartis of Switzerland will begin a five-year, $...any will dramatically increase its investment in i...
(Date:11/9/2009)... Fast food chains are often blamed for th...poll by Fitness.com.au however finds that 80% of p...nsibility. , (PRWEB) Nove...nd video games were behind Australia’s obesi...an just innocent bystanders. A recent survey commi...
(Date:11/9/2009)... Tomorrow may be too late when it comes t...cording to TOPS Club, Inc. (Take Off Pounds Sensib...n. , (Vocus) November 9, ...preventing or improving a diabetes condition, acco...), the nonprofit weight-loss support organization....
(Date:11/9/2009)... Course, to be Offered in April 2010, Pro... Cambridge, MA (Vocus) Nove...for Human Rights (PHR) first inspected a suspected...realized he would need a team of experts to help i...ite properly was a key first step in securing evid...
(Date:11/9/2009)... New study highlights positive influence ... Rosemont, IL (Vocus) November 9, 2...ealth decreases. Recent research has highlighted t...to help prevent these issues. However, a new study...ts Health: A Multidisciplinary Approach reveals t...
Breaking Medicine News(10 mins):Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:Fitness.com.au Poll Finds 80% Blame Parents For Our Overweight Kids 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 2Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 4Health News:High Impact Sports Participation May Improve Bone Mineral Density in Mature Athletes 2
...ce in Primary and Key Secondary Endpoints at Both,...aintenance Effects Seen in,the First Phase II Stud...FORD, England, October 16 /PRNewswire-FirstCall/,-...omnia patients with daytime sleepiness. These top-...
...16 Many routine surgical biopsies,could become a ...aring,reviewing and diagnosing noninvasive digital...d Inc.,s VivaNet(TM) telemedicine server and its,V...urgically biopsy many,patients. "VivaScope imaging...
...utive to Lead Growing Medical Device Firm, SANTA ...eading provider of innovative medical devices used...ons for the minimally invasive treatment of,deep v...utive Officer. Mr. Cramer joined Bacchus Vascular...
...he following is an,event announcement from the Bro...00 a.m. - 10:30 a.m., The Brookings Institution ...shington, DC, Donor assistance for health-related...ed to achieve the Millennium,Development Goals. Ad...
... Wyeth (NYSE: WYE ),confirmed today that it will...rrester v. Wyeth cases in the Second Judicial Dist...al motions to The Honorable Robert H. Perry,who pr...General Counsel.,"The events of last week and the ...
... 15 HealthSouth,Corporation (NYSE: HLS ) today a...at 8:30 a.m. Eastern Time on Tuesday, November 6, ... of 2007. The conference call may be accessed by ...mately 10 minutes before the,start of the call to ...
Other Medicine News:Health News:Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness 2Health News:Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness 3Health News:Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness 4Health News:Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness 5Health News:Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness 6Health News:Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness 7Health News:Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness 8Health News:Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness 9Health News:Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness 10Health News:VivaScope(R) Confocal Imager May Eliminate Need for Routine Skin Biopsies for Dermatology Patients 2Health News:Bacchus Vascular Names Scott Cramer as President and CEO 2Health News:Brookings: Donor Perspectives on Innovative Financing for Global Health 2Health News:Wyeth to Appeal Nevada Hormone Therapy Trial Verdict 2Health News:Wyeth to Appeal Nevada Hormone Therapy Trial Verdict 3Health News:HealthSouth Announces Date of Third Quarter Earnings Conference Call 2
(Date:11/9/2009)...K, Nov. 9 MISSION Skincare®, ...star Serena Williams, soccer professional Mia Hamm...g "Active Lifestyle Skincare Destinations" in the ...ions across the country beginning this week. Stock...oducts, MISSION and CVS/pharmacy have set out to e...
(Date:11/9/2009)... Mass., Nov. 9 Groundbreaking arti...gement, for the first time explore, in depth, th...s for health care providers and its potential bene...es, University of Washington authors, Sunil Aggarw... Scientist Training Program and who conducted the ...
(Date:11/9/2009)...LE, Md., Nov. 9 OriGene Technologi...logy in Sweden has adopted its VERIFY Tagged Antig...ein Atlas program. This program is funded by the K...to explore the human proteome systematically using...ty mono-specific antibodies in a high throughput m...
Breaking Medicine Technology:Glamour Magazine Woman of the Year and MISSION Skincare Co-Founder, Serena Williams, Teams Up with CVS/pharmacy to Launch National 'Active Lifestyle Skincare Destinations' 2Glamour Magazine Woman of the Year and MISSION Skincare Co-Founder, Serena Williams, Teams Up with CVS/pharmacy to Launch National 'Active Lifestyle Skincare Destinations' 3Medicinal Use of Marijuana: Past, Present and Future...A Fresh Look by Experts in the Field 2Royal Institute of Technology Adopts OriGene Over-Expression Lysates in Human Proteome Atlas Program 2JDRF award supports study of potential target for blocking type 1 diabetes 56008 1JDRF award supports study of potential target for blocking type 1 diabetes 56008 2DNA mutations linked to diabetes 9759 1Hill Rom and Radianse Announce Partnering Agreement to Integrate Location Sensing Technology into NaviCare 28R 29 Nurse Call 56004 1Hill Rom and Radianse Announce Partnering Agreement to Integrate Location Sensing Technology into NaviCare 28R 29 Nurse Call 56004 2Hill Rom and Radianse Announce Partnering Agreement to Integrate Location Sensing Technology into NaviCare 28R 29 Nurse Call 56004 3Hill Rom and Radianse Announce Partnering Agreement to Integrate Location Sensing Technology into NaviCare 28R 29 Nurse Call 56004 4
...s Overall Psychological Toll Is Greater Than for A...Pa., May 17, 2007 /PRNewswire/ -- Nearly three out...cent) responding to a,new nationwide survey say no...urthermore, they describe UC as disruptive when it...cent), their sexual,relations (75 percent) and the...
...USALEM--(BUSINESS WIRE)--May 17, 2007 - BioLineRx ...nt company, announced today,that abstracts contain...linical trails of BL-1020, first in class GABA-enh...enia, have been,accepted for poster presentations ...will be presented at the following,conferences:, -...
Other Medicine Technology:Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 2Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 3Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 4Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 5Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 6Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 7Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 8Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 9BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming,Clinical Conferences 2BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming,Clinical Conferences 3
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: